Akhilesh Kumar

Akhilesh Kumar, PhD, serves as an Assistant Professor in the Department of Medicine at the University of Minnesota Medical School, specializing within the Division of Hematology, Oncology & Transplantation. His academic appointment bridges regenerative medicine and oncology, focusing on the development of novel cellular therapies through stem cell engineering and immunological research.

Dr. Kumar's research program centers on hematopoietic stem cell differentiation, with particular emphasis on T cell and natural killer cell development from pluripotent stem sources. His work investigates molecular regulators like BCL11B in lymphoid specification and explores therapeutic targets such as DLL3 in neuroendocrine tumors. Current projects include engineering multi-antigen targeting cellular therapies for thoracic cancers and multiple myeloma, generating vasculogenic cell populations for regenerative applications, and enhancing natural killer cell function through metabolic modulators like nicotinamide. This research integrates stem cell biology, immunology, and translational oncology to address unmet needs in cancer treatment.

Analysis of Dr. Kumar's recent publications (2023-2025) reveals a strong translational focus with significant contributions to hematopoietic development and cancer immunotherapy. His team has pioneered methods for arterial hemogenic endothelium production, elucidated transcription factor networks in blood cell specification, and advanced clinical applications including NK cell therapy for lymphoma. The work demonstrates interdisciplinary reach, spanning from basic mechanisms of lymphoid development to computational approaches in drug delivery and building aerodynamics, reflecting collaborative efforts across engineering, computational biology, and clinical oncology domains.